Humana Inc. $HUM Shares Bought by Focus Partners Wealth

Key Points

• Focus Partners Wealth increased its stake in Humana Inc. by 104.2%, acquiring an additional 3,281 shares, bringing its total holdings to 6,429 shares worth approximately $1.7 million.
• A range of institutional investors, including Cary Street Partners and Applied Finance Capital Management, also boosted their positions, leading to institutional ownership of 92.38% of Humana's stock.
• Despite a slight dip in share price by 1.2%, analysts have mixed views on Humana, with target prices ranging from $275.00 to $348.00 and an average rating of "Hold" according to current evaluations.

Focus Partners Wealth grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 104.2% in the first quarter, according to its most recent filing with the SEC. The fund owned 6,429 shares of the insurance provider's stock after acquiring an additional 3,281 shares during the period. Focus Partners Wealth's holdings in Humana were worth $1,701,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares during the last quarter. Applied Finance Capital Management LLC boosted its position in shares of Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after buying an additional 48 shares during the period. Achmea Investment Management B.V. boosted its position in shares of Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. boosted its position in shares of Humana by 6.1% in the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after buying an additional 50 shares during the period. Finally, Townsquare Capital LLC boosted its position in shares of Humana by 2.8% in the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Barclays raised their target price on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research report on Friday, September 5th. Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a report on Thursday, August 14th. Wall Street Zen lowered Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Sanford C. Bernstein increased their price objective on Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Finally, Morgan Stanley cut their price objective on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $289.24.

Humana Trading Down 1.2%

Shares of NYSE:HUM opened at $272.04 on Wednesday. The company has a market cap of $32.72 billion, a P/E ratio of 20.88, a P/E/G ratio of 1.62 and a beta of 0.44. The stock's 50-day moving average is $266.79 and its 200-day moving average is $257.30. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $324.38. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio (DPR) is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.